A detailed history of Ingalls & Snyder LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Ingalls & Snyder LLC holds 1,347 shares of TMO stock, worth $705,895. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,347
Previous 1,200 12.25%
Holding current value
$705,895
Previous $664,000 25.45%
% of portfolio
0.03%
Previous 0.03%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$531.86 - $624.21 $78,183 - $91,758
147 Added 12.25%
1,347 $833,000
Q2 2024

Jul 31, 2024

BUY
$541.52 - $599.02 $17,328 - $19,168
32 Added 2.74%
1,200 $664,000
Q1 2024

May 13, 2024

SELL
$528.82 - $599.43 $2,115 - $2,397
-4 Reduced 0.34%
1,168 $679,000
Q4 2023

Jan 29, 2024

SELL
$431.41 - $532.94 $112,166 - $138,564
-260 Reduced 18.16%
1,172 $622,000
Q3 2023

Nov 02, 2023

SELL
$498.29 - $574.41 $3,986 - $4,595
-8 Reduced 0.56%
1,432 $725,000
Q2 2023

Jul 27, 2023

BUY
$508.46 - $591.13 $14,745 - $17,142
29 Added 2.06%
1,440 $751,000
Q1 2023

May 09, 2023

BUY
$535.0 - $604.82 $3,210 - $3,628
6 Added 0.43%
1,411 $813,000
Q4 2022

Jan 31, 2023

SELL
$484.71 - $571.37 $8,724 - $10,284
-18 Reduced 1.26%
1,405 $774,000
Q3 2022

Oct 21, 2022

BUY
$507.19 - $604.49 $9,129 - $10,880
18 Added 1.28%
1,423 $722,000
Q2 2022

Aug 11, 2022

SELL
$500.9 - $612.21 $10,518 - $12,856
-21 Reduced 1.47%
1,405 $763,000
Q1 2022

May 09, 2022

SELL
$524.0 - $644.92 $3,668 - $4,514
-7 Reduced 0.49%
1,426 $842,000
Q4 2021

Feb 11, 2022

SELL
$569.0 - $667.24 $14,794 - $17,348
-26 Reduced 1.78%
1,433 $956,000
Q3 2021

Oct 27, 2021

BUY
$509.53 - $609.78 $61,143 - $73,173
120 Added 8.96%
1,459 $834,000
Q2 2021

Aug 03, 2021

BUY
$441.0 - $508.24 $1,323 - $1,524
3 Added 0.22%
1,339 $675,000
Q1 2021

Apr 21, 2021

SELL
$439.85 - $518.83 $19,793 - $23,347
-45 Reduced 3.26%
1,336 $610,000
Q4 2020

Jan 27, 2021

SELL
$435.06 - $527.66 $93,972 - $113,974
-216 Reduced 13.53%
1,381 $643,000
Q3 2020

Oct 21, 2020

BUY
$359.77 - $441.52 $54,685 - $67,111
152 Added 10.52%
1,597 $705,000
Q2 2020

Jul 31, 2020

BUY
$275.2 - $362.34 $1,100 - $1,449
4 Added 0.28%
1,445 $524,000
Q1 2020

Apr 22, 2020

SELL
$255.3 - $340.05 $56,421 - $75,151
-221 Reduced 13.3%
1,441 $409,000
Q3 2019

Oct 16, 2019

BUY
$268.46 - $305.43 $30,872 - $35,124
115 Added 7.43%
1,662 $484,000
Q2 2019

Jul 11, 2019

SELL
$257.51 - $295.55 $63,089 - $72,409
-245 Reduced 13.67%
1,547 $454,000
Q1 2019

Apr 11, 2019

SELL
$212.17 - $273.72 $7,001 - $9,032
-33 Reduced 1.81%
1,792 $491,000
Q4 2018

Jan 24, 2019

BUY
$208.47 - $251.98 $6,879 - $8,315
33 Added 1.84%
1,825 $408,000
Q3 2018

Oct 24, 2018

SELL
$205.57 - $244.32 $61,671 - $73,296
-300 Reduced 14.34%
1,792 $437,000
Q4 2017

Jan 19, 2018

BUY
$182.03 - $200.37 $380,806 - $419,174
2,092
2,092 $397,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $205B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Ingalls & Snyder LLC Portfolio

Follow Ingalls & Snyder LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.